Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial

NCT01555658 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Bivalirudin
DRUG: Unfractioned Heparin

Sponsor

University of Roma La Sapienza